DR. DAVID PAUL OLSON, MD
Medical Practice in Ann Arbor, MI
License number
Michigan 223743
Category
Medical Practice
Type
Pediatrics
License number
Michigan 4301097647
Category
Medical Practice
Type
Pediatrics
License number
Michigan 4301097647
Category
Medical Practice
Type
Pediatric Endocrinology
Address
Address
1500 C. S. Mott CHILDREN'S HOSPITAL FLOOR 8TH, Ann Arbor, MI 48109
Phone
(734) 936-4185
(734) 936-2047
(734) 936-2047
Personal information
See more information about DAVID PAUL OLSON at radaris.comName
Address
Phone
515 N Elmwood Ave, Traverse City, MI 49684
5130 Meadowbrook Ln, Flushing, MI 48433
467 Chalfonte Ave, Grosse Pointe Farms, MI 48236
4660 Morningside Dr Se, Grand Rapids, MI 49512
321 1St St, Menominee, MI 49858
Professional information
See more information about DAVID PAUL OLSON at trustoria.com
David Paul Olson, Ann Arbor MI
David Paul Olson, Ann Arbor MI
Specialties:
Pediatric Endocrinologist
Address:
3621 S State St, Ann Arbor, MI 48108
Education:
Doctor of Medicine
Board certifications:
American Board of Pediatrics Certification in Pediatrics, American Board of Pediatrics Sub-certificate in Pediatric Endocrinology (Pediatrics)
Dr. David P Olson, Boston MA - MD (Doctor of Medicine)
Dr. David P Olson, Boston MA - MD (Doctor of Medicine)
Specialties:
Pediatric Endocrinology
Address:
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
(617) 355-6000 (Phone)
University Mchgn Ped Endocrnlgy
1500 E Medical Center Dr SUITE 5718, Ann Arbor 48109
(734) 764-5175 (Phone)
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
(617) 355-6117 (Phone), (617) 738-7066 (Fax)
300 Longwood Ave, Boston 02115
(617) 355-6000 (Phone)
University Mchgn Ped Endocrnlgy
1500 E Medical Center Dr SUITE 5718, Ann Arbor 48109
(734) 764-5175 (Phone)
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
(617) 355-6117 (Phone), (617) 738-7066 (Fax)
Languages:
English
Hospitals:
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
University Mchgn Ped Endocrnlgy
1500 E Medical Center Dr SUITE 5718, Ann Arbor 48109
Hurley Medical Center
1 Hurley Plz, Flint 48503
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
300 Longwood Ave, Boston 02115
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
University Mchgn Ped Endocrnlgy
1500 E Medical Center Dr SUITE 5718, Ann Arbor 48109
Hurley Medical Center
1 Hurley Plz, Flint 48503
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Education:
Medical School
Univ Of Mi Med Sch
Graduated: 1995
Children'S Hospital Boston
Univ Of Mi Med Sch
Graduated: 1995
Children'S Hospital Boston
Methods And Compositions For The Inhibition Of Gene Expression
Methods And Compositions For The Inhibition Of Gene Expression
US Patent:
7524827, Apr 28, 2009
Filed:
Jun 1, 2004
Appl. No.:
10/858164
Inventors:
Reza Sheikhnejad - Saline MI, US
Mina Patel Sooch - W. Bloomfield MI, US
Neal Goodwin - Plainwell MI, US
David Olson - Ann Arbor MI, US
Mina Patel Sooch - W. Bloomfield MI, US
Neal Goodwin - Plainwell MI, US
David Olson - Ann Arbor MI, US
International Classification:
A61K 31/70, A01N 43/04, C07H 21/02, C07H 21/04
US Classification:
514 44, 536 231, 536 241, 536 243, 536 245
Abstract:
The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.
Transportable Flow Cytometer
Transportable Flow Cytometer
US Patent:
2007022, Sep 27, 2007
Filed:
Mar 22, 2006
Appl. No.:
11/387186
Inventors:
David Olson - Ann Arbor MI, US
Nathaniel Bair - Ann Arbor MI, US
Richard Fisher - Ann Arbor MI, US
Steve Martin - Ann Arbor MI, US
Collin Rich - Ypsilanti MI, US
Nathaniel Bair - Ann Arbor MI, US
Richard Fisher - Ann Arbor MI, US
Steve Martin - Ann Arbor MI, US
Collin Rich - Ypsilanti MI, US
International Classification:
G01N 33/48
US Classification:
436063000, 422073000
Abstract:
A first preferred embodiment includes a flow cytometer with a fluidic system to draw a sample fluid into an interrogation zone, a light source to emit light toward the sample fluid in the interrogation zone, an optic system to collect and detect at least one of a scattered light and a fluorescent light from the interrogation zone, and a processor. The flow cytometer, if properly boxed and labeled, complies with the parcel post requirements of the United States Postal Service. A second preferred embodiment includes the method of supplying a flow cytometer by shipping the flow cytometer via the United States Postal Service. A third preferred embodiment includes the method of servicing a flow cytometer by receiving the flow cytometer from a user via the United States Postal Service and servicing the flow cytometer.
Methods And Compositions For The Inhibition Of Gene Expression
Methods And Compositions For The Inhibition Of Gene Expression
US Patent:
2005028, Dec 29, 2005
Filed:
Jun 1, 2004
Appl. No.:
10/858341
Inventors:
Reza Sheikhnejad - Southfield MI, US
Mina Sooch - Bloomfield MI, US
Neal Goodwin - Plainwell MI, US
David Olson - Ann Arbor MI, US
Mina Sooch - Bloomfield MI, US
Neal Goodwin - Plainwell MI, US
David Olson - Ann Arbor MI, US
Assignee:
ProNAi Therapeutics, Inc. - Kalamazoo MI
International Classification:
C12N015/85, C12N015/88
US Classification:
435455000, 435458000
Abstract:
The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.
Methods And Compositions For The Inhibition Of Gene Expression
Methods And Compositions For The Inhibition Of Gene Expression
US Patent:
2006013, Jun 22, 2006
Filed:
Jun 1, 2004
Appl. No.:
10/858013
Inventors:
Reza Sheikhnejad - Southfield MI, US
Mina Sooch - Bloomfield MI, US
Neal Goodwin - Painwell MI, US
David Olson - Ann Arbor MI, US
Mina Sooch - Bloomfield MI, US
Neal Goodwin - Painwell MI, US
David Olson - Ann Arbor MI, US
International Classification:
A61K 48/00, C12N 15/87
US Classification:
514044000, 435455000
Abstract:
The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.
User Interface For A Flow Cytometer System
User Interface For A Flow Cytometer System
US Patent:
8229707, Jul 24, 2012
Filed:
Jul 4, 2011
Appl. No.:
13/175926
Inventors:
David Olson - Ann Arbor MI, US
Collin A. Rich - Ypsilanti MI, US
Collin A. Rich - Ypsilanti MI, US
Assignee:
Accuri Cytometers, Inc. - Ann Arbor MI
International Classification:
G06F 17/40, G06F 17/00
US Classification:
702189, 702 21, 702 45, 702 32, 356 39
Abstract:
A method of extracting and analyzing a data set from a flow cytometer system of the preferred embodiment comprises the steps of (1) running a sample and saving all collected raw data, (2) viewing raw (or “unmodified”) data, (3) modifying the raw data (e. g. , scaling and/or culling the raw data), (4) reviewing and saving the modified data, and (5) exporting the saved data. Once the sample has been run and all collected data have been saved, the user can repeat the steps of modifying the raw data, saving the modified data, and exporting the saved data as many times as necessary and/or desirable.
Methods And Compositions For The Inhibition Of Gene Expression
Methods And Compositions For The Inhibition Of Gene Expression
US Patent:
2006022, Oct 12, 2006
Filed:
Jun 1, 2004
Appl. No.:
10/858146
Inventors:
Reza Sheikhnejad - Southfield MI, US
Mina Sooch - W. Bloomfield MI, US
Neal Goodwin - Plainwell MI, US
David Olson - Ann Arbor MI, US
Mina Sooch - W. Bloomfield MI, US
Neal Goodwin - Plainwell MI, US
David Olson - Ann Arbor MI, US
International Classification:
A61K 48/00, C12N 15/88
US Classification:
514044000, 435455000, 435458000
Abstract:
The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.
Methods And Compositions For The Inhibition Of Gene Expression
Methods And Compositions For The Inhibition Of Gene Expression
US Patent:
2011013, Jun 9, 2011
Filed:
Jun 1, 2005
Appl. No.:
11/628424
Inventors:
Mina Patel Sooch - West Bloomfield MI, US
Neal Goodwin - Plainwell MI, US
David Olson - Ann Arbor MI, US
Neal Goodwin - Plainwell MI, US
David Olson - Ann Arbor MI, US
Assignee:
PRONAI THERAPEUTICS, INC. - Kalamazoo MI
International Classification:
A61K 48/00, A61K 9/127, C12N 15/88
US Classification:
424450, 435455, 435458, 514 44 R
Abstract:
The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.
Methods To Increase Dynamic Range And Improve Quantitative Analysis In Rapid Biosensors
Methods To Increase Dynamic Range And Improve Quantitative Analysis In Rapid Biosensors
US Patent:
7579184, Aug 25, 2009
Filed:
May 30, 2006
Appl. No.:
11/443531
Inventors:
Finny Mathew - East Lansing MI, US
David Olson - Ann Arbor MI, US
John Cunningham - Dexter MI, US
David Olson - Ann Arbor MI, US
John Cunningham - Dexter MI, US
Assignee:
Board of Trustees of Michigan State University - East Lansing MI
International Classification:
G01N 33/553
US Classification:
4352872, 204400, 20440301, 422 8201, 435 6, 4352871, 4352879, 4352885, 436524, 436525, 436806
Abstract:
Conductimetric assay devices that have both low end and high end sensitivity are described. The geometric shape and/or arrangement of the capture zones make it possible for the assay devices to have both low end and high end sensitivity. Also described is a conductimetric assay device having a pre-capture zone to capture unbound analyte. The assay device overcomes the problem of flooding by the analyte.